Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Nov 9;8:1390. doi: 10.1038/s41467-017-01565-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 5 — The effect of NucA modification on the cytotoxicity of the conjugated PTX. a The cell viabilities of SKOV3, OVCAR3, and L02 after 24 h treatment of NucA, CRO, PTX, CRO-PTX, or NucA-PTX evaluated by CCK8 assay. The concentration range of each compound was from 15.6 to 500 nM. The data were presented as the means ± standard deviation. n = 3. b The cell cycle distribution of SKOV3 and OVCAR3 cells after 48 h treatment of CRO-PTX, NucA-PTX, or PTX analyzed by flow cytometry